Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10316 studies found for:    Communicable Diseases: Clinical Trials
Show Display Options
Rank Status Study
21 Completed A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection
Condition: HIV Infections
Interventions: Biological: rgp120/HIV-1MN;   Biological: rgp120/HIV-1 SF-2;   Biological: gp160 Vaccine (MicroGeneSys)
22 Completed A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses
Condition: Malaria
Intervention: Biological: PfSPZ Vaccine
23 Enrolling by invitation A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Condition: Hepatitis C Virus Infection
Interventions: Drug: Sofosbuvir (SOF);   Drug: Ledipasvir/Sofosbuvir (LDV/SOF)
24 Recruiting The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
Condition: Urinary Tract Infections
Interventions: Drug: Trimethoprim sulfamethoxazole, cefixime, or cephalexin;   Drug: Placebo
25 Recruiting A Prospective Randomized Trial to Assess PO Versus IV Antibiotics for the Treatment of Post-op Wound Infection After Extremity Fractures
Condition: Wound Infection
Intervention: Other: PO versus IV antibiotics Route of administration evaluation
26 Completed Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
Condition: HIV Infections
Intervention:
27 Completed Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
Conditions: Latent Tuberculosis Infection;   Tuberculosis
Interventions: Biological: RUTI;   Biological: RUTI Matching Placebo
28 Completed Individual Patient Data-based Re-analysis of Synthesized Prior Randomized Clinical Trial Data Assessing the Effect of Steroids on Post-resuscitation Infections
Conditions: Infections;   Cardiac Arrest
Intervention: Drug: Stress-dose hydrocortisone
29 Completed VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases
Condition: Healthy
Intervention:
30 Terminated Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
Condition: Tuberculosis
Intervention: Drug: I ( isoniazid), II (isoniazid + rifampin )
31 Completed "Alcohol Based Hand Sanitizers for the Prevention of Acute Diarrheal Disease and Acute Respiratory Infection in Children Under 5 Attending Childcare Centers in Bogotá, Cundinamarca and Tolima, in Colombia: a Cluster Randomized Control Trial"
Conditions: Acute Diarrheal Disease;   Acute Respiratory Infection
Intervention: Other: ABHS use
32 Recruiting Impact of Structured Communication in the OR on Surgical Site Infections: Prospective Observational Clinical Trial
Conditions: Incidence of Surgical Site Infection;   Short Intraoperative Briefings;   Mortality;   Shared Mental Model
Interventions: Procedure: StOP? - Control group;   Procedure: StOP? - Intervention group
33 Completed Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity
Conditions: Infection; Cesarean Section;   Surgical Wound Infection;   Endometritis
Interventions: Other: 80% inhaled oxygen via non-rebreather mask;   Other: 30% inhaled oxygen via nasal cannula
34 Terminated
Has Results
Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)
Condition: Urinary Tract Infections
Interventions: Drug: MK0826 (ertapenem);   Drug: Comparator: meropenem
35 Completed Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children
Condition: Acute Upper Respiratory Tract Infections
Interventions: Drug: Ergoferon;   Drug: Placebo
36 Recruiting Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%
Condition: Catheter Related Blood Stream Infections
Intervention: Device: TauroSept®
37 Completed Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
Conditions: Ventilator Associated Pneumonia (VAP);   Other Infections;   Antibiotic-Associated Diarrhea;   C-Difficile;   Duration of Mechanical Ventilation;   Length of ICU Stay;   Length of Hospital Stay;   ICU and Hospital Mortality
Interventions: Drug: L. rhamnosus GG - Probiotic;   Other: Placebo - Microcrystalline Cellulose
38 Completed Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
Condition: MRSA Infection
Interventions: Drug: trimethoprim-sulfamethoxazole (TMP-SMX);   Drug: Linezolid;   Drug: Rifampicin
39 Completed Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia
Condition: Helicobacter Pylori Infection
Interventions: Drug: Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole);   Drug: Clarithromycin, Amoxicillin, Omeprazole
40 Completed Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal Infection
Intervention: Drug: Mupirocin calcium

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years